|
|
||||||||
1 Department of Medicine and Therapeutics2 Hong Kong Institute of Diabetes and Obesity3 Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, China4 Tianjin Cancer Hospital and Institute, Tianjin, China
(Correspondence should be addressed to J C N Chan; Email: jchan{at}cuhk.edu.hk)
Type 2 diabetic patients have increased cancer risk. We developed and validated an all-site cancer risk score in a prospective cohort of 7374 Chinese type 2 diabetic patients free of known history of cancer at enrolment, using split-half validation. Spline Cox model was used to detect common risk factors of cancer and to guide linear transformation of non-linear risk factors. After a median follow-up period of 5.45 years, 365 patients (4.95%) developed cancer. Body mass index (BMI; <24.0 or
27.6 kg/m2), triglyceride (
0.81 to <1.41 mmol/l), high-density lipoprotein cholesterol (<0.9 or
1.8 mmol/l), total cholesterol (<4.3 mmol/l) and white blood cell (WBC) count (<5.8x109 count per litre) were associated with increased cancer risks and exhibited non-linear relationships. We further linear transformed these terms for selection using backward Cox regression (P<0.05 for stay) in the training dataset. In the test dataset, calibration was checked using Hosmer–Lemeshow test and discrimination checked using area under receiver operating characteristic curve. In addition to age and current smoking, only linear-transformed total cholesterol and WBC count were selected. The risk score was 0.0488xage (years)–0.5810xtotal cholesterol (mmol/l, coded to 4.3 if >4.3)–0.3596xWBC count (109 counts/l, 5.8 if >5.8)+0.6390xcurrent smoking status (1 if yes). The 5-year probability of cancer was 1–0.9590EXP(0.9382x(RISK SCORE+1.5903)).The predicted cancer probability was not significantly different from the observed cancer probability during the 5-year follow-up. The adjusted area under receiver operating characteristic curve was 0.712. In conclusion, BMI, lipids and WBC count have predicting values for cancer.
This article has been cited by other articles:
![]() |
X. Yang, W. Y. So, R. C.W. Ma, G. T.C. Ko, A. P.S. Kong, H. Zhao, A. O.Y. Luk, C. W.K. Lam, C. S. Ho, P. C.Y. Tong, et al. Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry Diabetes Care, October 1, 2009; 32(10): 1826 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, H. Zhao, Y. Sui, R. C.W. Ma, W. Y. So, G. T.C. Ko, A. P.S. Kong, R. Ozaki, C. Y. Yeung, G. Xu, et al. Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes Diabetes, July 1, 2009; 58(7): 1518 - 1525. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |